25
2023
-
04
Shandong Yumankun Biotechnology Co., Ltd. was awarded the title of "Specialized, Specialized and New" by small and medium-sized enterprises in Shandong Province.
Classification:
News
Company News
The title of "Specialized, Specialized and New" for small and medium-sized enterprises in Shandong Province is of great significance for the company's future development direction. First of all, the title of "Specialized, Specialized, Specialized and New" means that Shandong Yumankun Bio-technology Co., Ltd. has outstanding performance in technological research and development and innovation ability. This is a kind of honor and recognition for the company, which enhances the brand value and market competitiveness of the company. At the same time, it will attract more excellent talents to join the company and further enhance the company's technical level and innovation ability. Secondly, obtaining this title also means that Shandong Yumankun Biotechnology Co., Ltd. has specialized knowledge and experience in specific fields. This will help the company to be more clear about the development direction and concentrate its resources and energy on the deep plowing in the specific field. By focusing on R&D and innovation in specific fields, the company will continue to improve its technical strength and market position in the field. Secondly, obtaining this title is of guiding significance to the future development direction of the Company. The Company will further clarify the Company's strategic objectives and development direction. The Company will further strengthen its technological research and development and innovation capabilities to improve the quality and competitiveness of its products. The company will strive to build a world-class specialized and new enterprise with outstanding specialty, innovation-driven, lean management and obvious features.
Previous article
Related News
2023-11-08
On November 6, the ninth batch of national drug centralized volume purchasing meeting was held in Shanghai. Shandong Yumangkun Biotechnology Co., Ltd. consistency evaluation over the evaluation of the product piracetam injection was selected.
2023-09-27
Good News｜Shandong Yumankun Biotechnology Co., Ltd. won the eighth batch of national centralized purchasing of pharmaceutical products.
2023-09-09
Circular of the National Medical Security Bureau on Further Deepening the Intelligent Audit and Monitoring of the Medical Security Fund
2023-08-30
Notice on the Filling of Information on Drugs Related to the Ninth Batch of Centralized Purchasing of Drugs by State Organizations
Address: Room 2602, Huiyuan Building, 38 Huaneng Road, Lixia District, Jinan City, Shandong Province
©Shandong Yumankun Biotechnology Co., Ltd.